While the market ditched shares of many other diagnostics firms, analysts said the reaction was overblown, particularly in the case of Quidel and molecular diagnostics players.
GenMark said it intends to use the proceeds for general corporate purposes that may include an expansion of its menu and increasing its manufacturing capacity.
Grants awarded to Chembio, BD, and FIND will help fund new diagnostic tests for Ebola and other fever-inducing illnesses and feasibility studies to evaluate them.
